As an internationally recognized tumor immunologist, Dr. Hwu has led pioneering research and clinical efforts to better understand the interactions between tumors and the immune system. He helped launch the field of gene-modified T cells, publishing research on the first chimeric antigen receptor directed against cancer. His work focuses on vaccines, adoptive T-cell therapies and immune resistance. An internationally recognized physician-scientist, Hwu has a proven track record leading collaborative teams to make breakthroughs in science while improving cancer outcomes for cancer patients.